Novo Nordisk A S annual gross profit
2019
2020
2021
2022
2023
2024
2025
Novo Nordisk A S Gross Profit Growth & History (NVO)
Novo Nordisk A S's gross profit was kr250.28B for fiscal 2025.
View full Novo Nordisk A S company overviewNovo Nordisk A S annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | kr250.28B | kr4.39B | +1.79% |
| 2024 | 2024-12-31 | kr245.88B | kr49.38B | +25.13% |
| 2023 | 2023-12-31 | kr196.50B | kr47.99B | +32.32% |
| 2022 | 2022-12-31 | kr148.51B | kr31.36B | +26.77% |
| 2021 | 2021-12-31 | kr117.14B | kr11.13B | +10.50% |
| 2020 | 2020-12-31 | kr106.01B | kr4.08B | +4.00% |
| 2019 | 2019-12-31 | kr101.93B | — | — |
Novo Nordisk A S quarterly gross profit
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | kr61.39B | −kr2.62B | −4.10% |
| Q1 2026 | 2026-03-31 | kr83.22B | kr18.03B | +27.65% |
| Q4 2025 | 2025-12-31 | kr64.00B | −kr8.66B | −11.92% |
| Q3 2025 | 2025-09-30 | kr57.07B | −kr2.93B | −4.88% |
| Q2 2025 | 2025-06-30 | kr64.01B | kr6.22B | +10.77% |
| Q1 2025 | 2025-03-31 | kr65.20B | kr9.76B | +17.61% |
| Q4 2024 | 2024-12-31 | kr72.66B | — | — |
| Q3 2024 | 2024-09-30 | kr60.00B | — | — |
| Q2 2024 | 2024-06-30 | kr57.79B | — | — |
| Q1 2024 | 2024-03-31 | kr55.43B | — | — |
Novo Nordisk A S gross profit trends
Over the last five fiscal years, Novo Nordisk A S's gross profit increased from kr106.01B to kr250.28B, a change of kr144.26B. The latest reported quarter, Q2 2026, shows kr61.39B.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novo Nordisk A S source filings ↗Community posts
Novo Nordisk reports positive STEP Young results in children aged 6 to under 12
Novo Nordisk announced first STEP Young Phase 3 results on 7 September 2026. Trial design and outcome The randomised, double-blind study involved 165 children aged 6 to under 12, comparing weekly semaglutide with placebo. Both groups receiv ...